Equity Rights Offering
Company: Core Scientific
The claim, verbatim
The company commenced an equity rights offering of common shares of the reorganized company in an aggregate amount of $55 million, which was oversubscribed
Source (primary)
Core Scientific 8-K filed 2024-01-08 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “on November 20, 2023, the Company commenced an equity rights offering (the " Equity Rights Offering ") of common shares of the reorganized Company (the " ERO Shares ") in an aggregate amount of $55 million”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 8-K filed 2024-01-08
Quote: “on November 20, 2023, the Company commenced an equity rights offering (the " Equity Rights Offering ") of common shares of the reorganized Company (the " ERO Shares ") in an aggregate amount of $55 million”